State Approvals
Board of Pharmacy Approvals
States where GHA is recognized to conduct non-resident inspections for 503A compounding pharmacies, 503B outsourcing facilities, and monitoring services.
503A Approved
503B Approved
Monitoring
Pending
17 states approved2 pending50 totalUpdated February 26, 2026
AlabamaAL
AlaskaAK
ArizonaAZ
ArkansasAR
CaliforniaCAMonitoring
Approved to provide monitoring services during probationary periods.
ColoradoCO
ConnecticutCT503A503B
DelawareDE
FloridaFL503A503B
GeorgiaGA
HawaiiHI
IdahoID
IllinoisIL
IndianaIN
IowaIA503A503B
KansasKS
KentuckyKY503A503B
LouisianaLA
MaineMEPending
Currently in discussions or awaiting recognition from the Board of Pharmacy.
MarylandMD
MichiganMI503A503B
MinnesotaMN
MississippiMS503A503B
MissouriMO
MontanaMT
NebraskaNE
NevadaNV
New HampshireNH503A503B
New JerseyNJ503A503B
New MexicoNM503A503B
New YorkNYPending
Currently in discussions or awaiting recognition from the Board of Pharmacy.
North CarolinaNC
North DakotaND
OhioOH
OklahomaOK
OregonOR
PennsylvaniaPA
Rhode IslandRI503A503B
South CarolinaSC
South DakotaSD
TennesseeTN
TexasTX
UtahUT
VermontVT503A503B
VirginiaVA503A
Approved for 503A inspections only.
WashingtonWA503A503B
West VirginiaWV503A
Approved for 503A inspections only.
WisconsinWI503A503B
Approved for both 503A and 503B inspections.
WyomingWY